Analysis of Misbranded Cosmetics using Direct Analysis in Real Time (DART) with Mass Detection and Confirmatory Analytical Techniques


  • Date
    March 27, 2018
  • Time
    8:00 a.m. PDT / 11:00 a.m. EDT / 16:00 BST / 17:00 CEST - Duration: 60 Minutes

Date : March 21, 2018
Time : 8:00 a.m. PDT / 11:00 a.m. EDT / 16:00 BST / 17:00 CEST - Duration: 60 Minutes
  • Overview

    The distinction between a cosmetic and a drug is important from a regulatory and safety perspective because, among other things, a cosmetic should not contain pharmaceutical active ingredients (AIs). Otherwise they are classified as a drug according to European Commission’s No. 1223/2009 and the U.S. FDA’s regulations on Cosmetics.

    In this webinar, we describe a study of several cosmetic products that contained prohibited pharmaceutical AIs such as corticosteroids. Several samples tested positive for prohibited skin lightening agents. Packaging labels were often misleading, and in some cases, the skin lightening agent was not listed on the enclosed product information increasing the potential of improper long-term use and adverse side effects to consumers.
    Read more

    Brought to you by:


    Waters Corporation
  • Speakers

    Dr. Marian Twohig, Ph.D.,
    Principal Scientist,
    Waters Corporation
    Linda Wang,
    Senior Editor,
    C&EN